Y. Shu

OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial

R. Wu, R. Yang, D. Lin, 2023, Journal of Thoracic Oncology.